These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9589081)

  • 1. Results of alternating chemotherapy and hyperfractionated radiation therapy in childhood rhabdomyosarcoma.
    Merchant TE; Cahill JC; Ghavimi F
    Med Pediatr Oncol; 1998 Jun; 30(6):332-8. PubMed ID: 9589081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS).
    Mandell LR; Ghavimi F; Exelby P; Fuks Z
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):197-203. PubMed ID: 2455700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer.
    Wang MH; Vos LJ; Yee D; Patel S; Pervez N; Parliament M; Usmani N; Danielson B; Amanie J; Pearcey R; Ghosh S; Field C; Fallone BG; Murtha AD
    Pract Radiat Oncol; 2021; 11(5):384-393. PubMed ID: 33705985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy.
    Jian JJ; Cheng SH; Tsai SY; Yen KC; Chu NM; Chan KY; Tan TD; Cheng JC; Lin YC; Leu SY; Hsieh CI; Tsou MH; Lin CY; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):344-52. PubMed ID: 12023138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five versus ten fractions per week radiotherapy in locally advanced head and neck cancer.
    Tallari RV; Singh OP; Yogi V; Yadav S
    J Cancer Res Ther; 2017; 13(2):224-229. PubMed ID: 28643738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials.
    Lehrer EJ; Kishan AU; Yu JB; Trifiletti DM; Showalter TN; Ellis R; Zaorsky NG
    Radiother Oncol; 2020 Jul; 148():235-242. PubMed ID: 32505965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperfractionated radiation therapy for head and neck cancers].
    Karasawa K; Hanyu N; Chang TC; Kuga G; Kaminuma T; Mitsuhashi T; Miyashita H
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1827-32. PubMed ID: 19011330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
    Massimino M; Gandola L; Giangaspero F; Sandri A; Valagussa P; Perilongo G; Garrè ML; Ricardi U; Forni M; Genitori L; Scarzello G; Spreafico F; Barra S; Mascarin M; Pollo B; Gardiman M; Cama A; Navarria P; Brisigotti M; Collini P; Balter R; Fidani P; Stefanelli M; Burnelli R; Potepan P; Podda M; Sotti G; Madon E;
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1336-45. PubMed ID: 15050308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy.
    Mandell L; Ghavimi F; Peretz T; LaQuaglia M; Exelby P
    J Clin Oncol; 1990 Sep; 8(9):1536-42. PubMed ID: 2391558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
    Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
    Regine WF; Fontanesi J; Kumar P; Zeitzer K; Greenwald C; Bowman L; Shapiro DN; Rao BN; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):799-805. PubMed ID: 7860391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma.
    Lyu J; Liu T; Li T; Li F; Wang Q; Wang J; Han Y; Wang J; Zhang J; Peng L; Lang J
    Cancer Med; 2019 Jul; 8(8):3710-3718. PubMed ID: 31119872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
    Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S
    J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer.
    Saeed NA; Jin L; Amini A; Verma V; Lester-Coll NH; Chen PH; Decker RH; Park HS
    Am J Clin Oncol; 2023 Feb; 46(2):66-72. PubMed ID: 36662872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
    Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
    J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiotherapy compared with conventionally fractionated radiotherapy to treat initial distant metastases in nasopharyngeal carcinoma: A multicenter, prospective, randomized, phase II trial.
    Liu J; Zhang B; Su Y; Qin G; Kong X; Mo Y; Zhang R; Jiang W
    Radiother Oncol; 2023 Oct; 187():109815. PubMed ID: 37480994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin.
    Gurney H; Harnett P; Kefford R; Boyages J
    Aust N Z J Med; 1998 Jun; 28(3):400-2. PubMed ID: 9673758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients.
    Butler-Xu YS; Marietta M; Zahra A; TenNapel M; Mitchell M
    Adv Radiat Oncol; 2019; 4(2):261-267. PubMed ID: 31011671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.